Petroleo Brasileiro S.A. Petrobras ADS (PBR)

Cost of Revenue

$14.11B

Quarterly · Period ending: · USD

PBR logo

PBR Cost of Revenue

Latest reported$14.11B
PBR Quarterly Cost of Revenue ($2.86B → $14.11B)
High-resolution chart · PNG

PBR cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Petroleo Brasileiro S.A. Petrobras ADS Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
14,114,000,000
12,931,792,000
13,830,487,256
12,260,000,000
11,025,000,000
10,685,000,000
10,832,000,000
11,361,000,000
11,740,000,000
11,511,000,000
12,453,000,000
11,982,000,000
11,727,889,736
12,975,196,826
15,592,000,000
15,875,000,000
15,240,000,000
12,779,000,000
13,452,000,000
11,863,000,000
10,158,000,000
7,487,207,732
10,839,912,194
6,868,000,000
6,064,000,000
9,879,000,000
10,864,000,000
11,855,000,000
10,800,000,000
12,213,000,000
16,074,000,000
14,162,000,000
12,347,000,000
14,704,000,000
15,804,000,000
15,988,000,000
14,181,000,000
14,174,000,000
14,477,000,000
14,506,000,000
13,818,000,000
12,616,000,000
15,160,000,000
16,484,000,000
17,701,000,000
18,140,000,000
24,760,000,000
29,859,000,000
28,470,000,000
26,388,000,000
28,119,000,000
26,707,000,000
26,531,000,000
26,897,000,000
31,577,805,003
27,542,272,322
26,502,000,000
25,959,000,000
32,031,000,000
23,779,864,274
25,716,000,000
20,673,000,000
19,509,000,000
18,472,000,000
17,456,000,000
15,257,000,000
13,950,000,000
14,350,000,000
10,862,000,000
10,020,000,000
13,569,000,000
23,458,000,000
20,078,000,000
15,380,000,000
14,069,000,000
13,761,000,000
11,202,000,000
10,757,000,000
11,706,000,000
11,819,000,000
9,295,000,000
8,250,000,000
9,500,000,000
8,723,000,000
7,408,000,000
5,206,000,000
6,433,000,000
5,863,000,000
4,439,000,000
4,058,000,000
4,047,000,000
4,196,000,000
4,014,000,000
3,159,000,000
3,509,000,000
2,767,000,000
3,090,000,000
2,575,000,000
3,329,000,000
3,274,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.